Cemiplimab With Fianlimab for Resectable Non-Metastatic Colon Cancer
Clinical trial NCT07224022 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07224022
- Sponsor
- John Strickler, M.D.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-01
- Primary completion
- 2028-08-31
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.